Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.89 USD | -0.31% |
|
+13.68% | +24.79% |
Feb. 12 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday | MT |
Feb. 12 | Alkermes plc, Q4 2024 Earnings Call, Feb 12, 2025 |
Capitalization | 5.84B 5.56B 5.24B 4.63B 8.27B 506B 9.18B 62.4B 23.12B 211B 21.88B 21.44B 887B | P/E ratio 2025 * |
31x | P/E ratio 2026 * | 31.9x |
---|---|---|---|---|---|
Enterprise value | 5.51B 5.25B 4.95B 4.37B 7.81B 478B 8.67B 58.94B 21.84B 200B 20.67B 20.25B 838B | EV / Sales 2025 * |
3.95x | EV / Sales 2026 * | 3.64x |
Free-Float |
90.15% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Alkermes plc
1 day | -0.31% | ||
1 week | +13.68% | ||
Current month | +13.83% | ||
1 month | +23.55% | ||
3 months | +27.31% | ||
6 months | +33.02% | ||
Current year | +24.79% |







Director | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 63 | 1991-01-31 |
Blair Jackson
DFI | Director of Finance/CFO | 52 | 2024-01-31 |
Thomas Harvey
CTO | Chief Tech/Sci/R&D Officer | - | 2004-12-31 |
Manager | Title | Age | Since |
---|---|---|---|
Richard Pops
CHM | Chairman | 63 | 2011-08-31 |
Nancy Snyderman
BRD | Director/Board Member | 73 | 2016-05-25 |
Shane Cooke
BRD | Director/Board Member | 62 | 2018-03-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.32% | 248 M€ | -3.41% | - | |
2.65% | 1 M€ | 0.00% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.31% | +13.68% | +10.23% | +53.97% | 5.84B | ||
-0.43% | -1.39% | +28.71% | -1.26% | 47.89B | ||
-1.33% | -7.06% | -19.89% | -15.40% | 34.06B | ||
-0.45% | -1.71% | -0.38% | +22.57% | 26.65B | ||
+0.04% | +6.58% | +72.73% | +81.40% | 16.54B | ||
+1.95% | -3.75% | -35.82% | -23.17% | 15.37B | ||
+6.79% | +29.70% | - | - | 14.08B | ||
+3.35% | +1.20% | -63.80% | -78.17% | 12.7B | ||
-1.12% | -9.44% | -7.47% | -36.10% | 10.42B | ||
-0.65% | -3.93% | -13.74% | +144.96% | 10.36B | ||
Average | +0.78% | +2.46% | -3.27% | +16.53% | 19.39B | |
Weighted average by Cap. | +0.36% | +0.48% | +2.05% | +8.09% |
2025 * | 2026 * | |
---|---|---|
Net sales | 1.4B 1.33B 1.25B 1.11B 1.98B 121B 2.19B 14.92B 5.53B 50.55B 5.23B 5.13B 212B | 1.45B 1.38B 1.31B 1.15B 2.06B 126B 2.29B 15.54B 5.76B 52.66B 5.45B 5.34B 221B |
Net income | 199M 190M 179M 158M 282M 17.27B 313M 2.13B 790M 7.22B 747M 732M 30.32B | 200M 191M 180M 159M 284M 17.35B 315M 2.14B 793M 7.26B 751M 736M 30.46B |
Net Debt | -323M -307M -290M -256M -457M -27.96B -507M -3.45B -1.28B -11.69B -1.21B -1.19B -49.07B | -544M -518M -488M -431M -771M -47.11B -855M -5.81B -2.15B -19.7B -2.04B -2B -82.7B |
Date | Price | Change | Volume |
---|---|---|---|
25-02-14 | 35.89 $ | -0.31% | 2,626,769 |
25-02-13 | 36.00 $ | +7.46% | 4,006,568 |
25-02-12 | 33.50 $ | +4.82% | 3,574,228 |
25-02-11 | 31.96 $ | +2.34% | 4,478,891 |
25-02-10 | 31.23 $ | -1.08% | 1,751,583 |
Delayed Quote Nasdaq, February 14, 2025 at 04:00 pm EST
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALKS Stock